Skip to content
‹ Back to IndustriesHealthcare

Health Catalyst’s Role in Healthcare Analytics in APAC

The future of the healthcare industry is increasingly being shaped by data and analytics. That’s why, for this episode of Owning the Future of Healthcare by Health Catalyst, host Daniel Litwin was joined by Farhana Nakhooda, Health Catalyst Senior Vice President of Healthcare and Life Sciences for APAC, who shared her influential insights. In particular,…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Health Catalyst’s Role in Healthcare Analytics in APAC

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI in a free MarketScale workspace. Qualifying companies also get one professional video edit a month. No credit card.

Try it Free

The future of the healthcare industry is increasingly being shaped by data and analytics. That’s why, for this episode of Owning the Future of Healthcare by Health Catalyst, host Daniel Litwin was joined by Farhana Nakhooda, Health Catalyst Senior Vice President of Healthcare and Life Sciences for APAC, who shared her influential insights.

In particular, Nakhooda contributed to an in-depth discussion about the organization’s impact on the efficient and equitable use of data and analytics in the Asia-Pacific region, or APAC.

Because the region is so large, Nakhooda said it’s impossible to generalize about universal trends in the area. However, when viewed through the lens of developed and developing markets, some easier-to-identify groupings and trends emerge.

While developed markets are more prepared for analytics than their developing counterparts thanks to, in many cases, years of EMR use, that doesn’t mean the adoption of more robust analytics will be simple. For example, digitization varies greatly among even developed markets, which can lead to implementation challenges.

Among developing markets, work is still centralized around enabling data capture in the first place.

Even though these segments of the region are at different stages of preparedness and adoption, Nakhooda said they do have some things in common, such as a requirement to share data with their governments.

Health Catalyst is working to help the region increase understanding of data security and the structure around data sharing and governance, as well as to help increase data and analytics literacy in the region, which is shining a spotlight on the power of data in improving outcomes and more.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0. No credit card. Company confirmation required.

More Healthcare Insights

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage. Holland & Knight said hospitals will be eligible for NTAP reimbursement for use of Aidoc’s CARE Body CT Multi-Triage beginning Oct. 1, 2026, with supplemental payments continuing for three years.

  • 01Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage.
  • 02Holland & Knight said CMS approved an NTAP designation for Aidoc’s CARE Body CT Multi-Triage, with hospitals eligible for NTAP reimbursement beginning Oct. 1, 2026, with supplemental payments continuing for three years.

Sep 23, 2026

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raised CAD $4.24 million in a pre-seed round, according to Fierce Healthcare. It plans to expand protocol-driven virtual specialty care across Canada and the U.S.

  • 01Blair Health raised CAD $4.24 million in pre-seed funding.
  • 02Qualified Health positions its AI platform around safety and governance, including clinician oversight, auditability and traceability, according to Fierce Healthcare.

Sep 23, 2026

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512